Mark E. Williams

机构：DuPont (United States), University of Kentucky · ORCID：0009-0003-5641-8836

发表论文 147 篇 · 总被引 11663 次 · h-index 46

代表论文

• Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial (2018 · Kidney International · 被引 107)
• Glycemic Management in ESRD and Earlier Stages of CKD (2014 · American Journal of Kidney Diseases · 被引 88)
• A pair of homoeolog ClpP5 genes underlies a virescent yellow‐like mutant and its modifier in maize (2014 · The Plant Journal · 被引 44)
• The function and allosteric control of the human sweet taste receptor (2020 · Advances in pharmacology · 被引 39)
• Diabetes Management in the Kidney Patient (2013 · Medical Clinics of North America · 被引 31)
• The G lycemic I ndices in D ialysis E valuation ( GIDE ) study: Comparative measures of glycemic control in diabetic dialysis patients (2015 · Hemodialysis International · 被引 30)